Cooperative Agreement U01GH002401

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $137,229 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Chulalongkorn University in Thailand. The grant, which runs from August 2024 to July 2029, focuses on two key objectives: Characterizing the host response and identifying novel biomarkers to accurately predict the severity of acute leptospirosis, a potentially life-threatening zoonotic disease. This will involve a...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $128,655 to the University of Pittsburgh to enhance surveillance methods for genomic epidemiology in healthcare. The project aims to test the hypothesis that combining real-time whole genome sequencing (WGS) surveillance of bacterial pathogens with targeted environmental cultures will improve identification and control...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of an alternative isothermal DNA amplification technique. The $151,496 award to the University of Central Florida will fund research to create a novel DNA amplification method using double-stranded primers that can produce high concentrations of amplified DNA similar to PCR, but without the need...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $1,438,589 to the University of Colorado-Denver to develop high-throughput methods that measure and identify DNA transduction within bacterial pathogens and microbiomes. The project aims to examine how transduction, the transfer of genetic material by bacterial viruses or virus-like particles, spreads virulence traits within the microbiota. A...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,553,810 to the University of Maryland, Baltimore to conduct genomic surveillance for artemisinin resistance in Africa. The project aims to identify parasite genetic adaptations and functional pathways associated with resistance to artemisinin-based combination therapies, the first-line treatment for malaria in...

This $537,619 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of a novel electrochemical biosensor technology capable of simultaneously detecting HIV, hepatitis B, and hepatitis C viruses. The project aims to integrate the recently developed four-way junction (4WJ) electrochemical biosensor with an isothermal nucleic acid amplification technique to create a...

The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $209,750 to Emory University to leverage antibody-omics technologies to prevent and detect tuberculosis (TB) in children affected by HIV. The key objectives are to: 1) Define antibody Fc features associated with protection from Mycobacterium tuberculosis (MTB) infection in infants with and without maternal HIV exposure, and 2) Identify...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $504,703 to the University of Georgia Research Foundation (UGA Research Foundation) to optimize and fully integrate an "UltraPCR" diagnostic platform for improved detection and assessment of treatment outcomes for Trypanosoma cruzi infection, the causative agent of Chagas disease. The overarching goal...

The Translational Genomics Research Institute (TGen) received a $1.3 million cooperative agreement award from the United States Department of Agriculture Animal and Plant Health Inspection Service under the Plant and Animal Disease, Pest Control, and Animal Care federal grant program (CFDA 10.025). The award will fund TGen to address gaps in SARS-CoV-2 surveillance and investigation activities in animals, including farmed animals, captive wildlife, free-ranging wildlife, and companion animals....